Opportunity Information: Apply for PAR 22 164

The National Cancer Institute (NCI), under NIH, is funding R01 research projects that take a communication science lens to cancer prevention and control in what the FOA calls the "new information ecosystem." The core idea is to support rigorous, innovative studies that reflect how people now encounter, share, and act on cancer information across digital platforms, social media, online communities, clinical settings, and interpersonal networks. Projects are expected to connect communication processes to concrete behavioral targets and measurable health outcomes tied to cancer prevention, screening, treatment decision-making, survivorship, and related areas. Clinical trials are allowed but not required, which means applicants can propose anything from observational and measurement-focused work to intervention testing, as long as the approach fits an R01-level scope.

The opportunity is organized around three main research domains. First, NCI is looking for work that advances cancer communication surveillance, meaning new or improved ways to monitor and understand the communication environment at scale. This can include novel methods for tracking exposure to cancer information, misinformation, message spread, engagement patterns, and changes over time, especially in rapidly shifting online spaces. The emphasis is on the utility and application of new surveillance approaches, so proposals should make clear how the surveillance method would actually be used to inform cancer prevention and control, identify disparities in information access or exposure, or detect emerging issues that affect public understanding and behavior.

Second, the FOA encourages the development and testing of rapid cancer communication interventions using innovative methods and study designs. This reflects a need to respond faster to evolving narratives, misinformation, news cycles, and platform changes that can influence cancer-related beliefs and decisions. Competitive projects in this domain would typically show how an intervention can be iterated, adapted, and evaluated efficiently while still maintaining scientific rigor. The intervention focus is communication-centered, such as message strategies, delivery channels, tailoring approaches, or platform-specific dissemination tactics, and the expectation is that applicants will use designs that fit fast-moving environments, rather than relying only on slower traditional models.

Third, NCI is specifically interested in multilevel cancer communication models that emphasize bidirectional influence between levels. In practice, that means projects should go beyond one-way "top-down" communication frameworks and instead examine how factors at different levels shape each other over time. Relevant levels can include individuals, families and social networks, communities, healthcare teams and organizations, media systems, and broader policy or structural contexts. Bidirectional influence implies feedback loops, such as how community narratives and online discourse affect healthcare interactions, and how healthcare guidance and institutional messaging feed back into social sharing and belief formation. Projects in this area should build or test models that capture these cross-level dynamics in a way that improves explanatory power and supports better intervention targeting.

Across all three domains, the FOA expects applicants to use one or more innovative communication research methodologies. While the announcement does not prescribe specific methods, the intent is to encourage modern approaches that match current information realities, such as advanced analytic techniques, novel data sources, adaptive or pragmatic designs, and tools that can measure communication processes in real time or near real time. Importantly, the methodological innovation should serve the cancer prevention and control goals, not just be innovation for its own sake. Strong applications will typically articulate why the chosen methods are necessary to answer the communication question and how they improve on conventional approaches.

This is a discretionary grant mechanism using the NIH R01 funding instrument (Funding Opportunity Number PAR 22 164). The activity category is listed under education and health, with CFDA number 93.399. The listed award ceiling is $500,000, indicating the opportunity is suited for substantial multi-year projects with enough scope to develop and validate methods, build models, or test interventions in meaningful populations or settings. The original closing date provided is 2025-09-07.

Eligibility is broad and includes many domestic organization types that commonly apply for NIH grants. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (as long as they are not institutions of higher education when listed in those categories); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions.

At the same time, the FOA draws clear boundaries around foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are not eligible to apply. Foreign components, as defined by the NIH Grants Policy Statement, are not allowed. In other words, applications must be fully domestic in both the applicant organization and the project components, without foreign components embedded in the work.

Taken together, this opportunity is aimed at strengthening the science of cancer communication under modern conditions where information is abundant, fragmented, and often contested. NCI is looking for projects that can more accurately observe the communication landscape, intervene quickly and effectively when communication problems arise, and explain cancer communication as a multi-level, dynamic system that includes feedback loops between individuals, communities, institutions, and media environments.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.399.
  • This funding opportunity was created on 2022-06-13.
  • Applicants must submit their applications by 2025-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 22 164

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: 1890 Institution Teaching, Research, and Extension Capacity Building Grants Program

Previous opportunity: Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 22 164

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 22 164) also looked into and applied for these:

Funding Opportunity
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Apply for PAR 22 198

Funding Number: PAR 22 198
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 026

Funding Number: RFA CA 22 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $5,500,000
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) Apply for PAR 22 199

Funding Number: PAR 22 199
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) Apply for RFA DA 23 052

Funding Number: RFA DA 23 052
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Registry of Medical Cannabis Use and Health Outcomes (UM1 - Clinical Trial Optional) Apply for RFA DA 23 011

Funding Number: RFA DA 23 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,500,000
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) Apply for PAR 22 173

Funding Number: PAR 22 173
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) Apply for PAR 22 174

Funding Number: PAR 22 174
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed) Apply for RFA DA 23 017

Funding Number: RFA DA 23 017
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $2,500,000
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) Apply for PAR 22 201

Funding Number: PAR 22 201
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only) Apply for RFA DA 23 018

Funding Number: RFA DA 23 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $2,500,000
HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional) Apply for RFA DA 23 046

Funding Number: RFA DA 23 046
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,500,000
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Not Allowed) Apply for RFA DA 23 045

Funding Number: RFA DA 23 045
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed) Apply for RFA NS 23 014

Funding Number: RFA NS 23 014
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) Apply for PAR 22 203

Funding Number: PAR 22 203
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,200,000
HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional) Apply for RFA DA 23 051

Funding Number: RFA DA 23 051
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) Apply for RFA AT 23 001

Funding Number: RFA AT 23 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) Apply for RFA AT 23 002

Funding Number: RFA AT 23 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required) Apply for PAS 22 207

Funding Number: PAS 22 207
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Apply for PAR 22 216

Funding Number: PAR 22 216
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) Apply for PAS 22 206

Funding Number: PAS 22 206
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 164", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: